15 results
Pathogenesis of Diabetic Ketoacidosis - Insulin deficiency or severe insulin insensitivity 

#DKA #Pathophysiology #Endocrinology #Diabetes #Ketoacidosis
Pathogenesis of Diabetic ... #Pathophysiology ... #Endocrinology ... #Diabetes #Ketoacidosis ... #Diabetic
Diabetes Medication Prescribing Algorithm

- Dr. Eric Strong @DrEricStrong - Strong Medicine https://www.youtube.com/c/EricsMedicalLectures/featured

#Diabetes #Medications #Prescribing #Algorithm #management
Diabetes Medication ... Prescribing Algorithm ... EricsMedicalLectures/featured #Diabetes ... #Medications #Prescribing ... Algorithm #management #endocrinology
Pathophysiology of Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar Syndrome (HHS)
Absolute Insulin deficit:
 - Type I DM:
Pathophysiology ... of Diabetic Ketoacidosis ... (DKA) and Hyperglycemic ... #comparison #endocrinology ... #diabetes #diabetic
Pathophysiology and Effects of Insulin Deficiency

#Insulin #Deficiency #DKA #Ketoacidosis #Diabetes #Pathophysiology #Endocrinology
Pathophysiology ... #Deficiency #DKA ... #Ketoacidosis #Diabetes ... #Pathophysiology ... #Endocrinology
Pathogenesis and Pathophysiology of Diabetic Ketoacidosis (DKA)

DKA is a result of an absolute or relative insulin
of Diabetic Ketoacidosis ... (DKA) DKA is ... #Diabetic #Ketoacidosis ... #DKA #Diabetes ... #Endocrinology
Diabetes Pathophysiology and Medication Targets

The ominous octet is one concept that summarizes the different pathophysiologic pathways
Diabetes Pathophysiology ... hyperglycemia in type 2 diabetes ... commonly used diabetes ... medications and ... /ambcarerx #Diabetes
Metformin - First Line Treatment for Diabetes Type 2
• Start with initial dose of 500 mg
Treatment for Diabetes ... than stopping medication ... #Metformin #Indications ... #Pharmacology #Diabetes ... #DM2 #Prescribing
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Action for Common Diabetes ... Medications ... sarahthelyon #Diabetes ... #Medications #pharmacology ... #endocrinology
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table Insulin ... EricsMedicalLectures/featured #diabetes ... #medications #table ... comparison #management #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... in Type 1 Diabetes ... monitors in Type 1 Diabetes ... pocketcardset #Diabetes ... DM2 #Inpatient #Medications